Express Pharma

GSK launches once daily, Single Inhaler-Triple Therapy for COPD patients

The launch follows the product’s approval by the Drugs Controller General of India (DCGI) for use of Trelegy Ellipta as maintenance treatment to prevent and relieve symptoms associated with COPD in patients aged 18 years and above

0 525